Phong Phu Pharmaceutical JSC (HNX:PPP)

Vietnam flag Vietnam · Delayed Price · Currency is VND
18,000
-700 (-3.74%)
At close: May 18, 2026
Market Cap164.56B +12.7%
Revenue (ttm)139.74B +1.6%
Net Income16.57B +6.9%
EPS1,883.11 +6.6%
Shares Out8.80M
PE Ratio9.93
Forward PEn/a
Dividend1,500.00 (8.02%)
Ex-Dividend DateMar 19, 2026
Volume2,200
Average Volume1,485
Open18,200
Previous Close18,700
Day's Range18,000 - 18,200
52-Week Range17,700 - 23,100
Betan/a
RSI40.19
Earnings DateApr 29, 2026

About HNX:PPP

Phong Phu Pharmaceutical Joint Stock Company engages in the production, sale, and distribution of medicines primarily in Vietnam. The company’s medicines are derived from medicinal herbs, pharmaceutical chemicals, and health supplements. It engages in wholesale of other household products; tea production; manufacture of dairy products, bakery products, macaroni, noodles and similar farinaceous products, non-alcoholic beverages, mineral waters, medical and dental, orthopedic and rehabilitation instruments supplies, cosmetics, soap and detergents... [Read more]

Founded 2000
Employees 204
Stock Exchange Hanoi Stock Exchange
Ticker Symbol PPP
Full Company Profile

Financial Performance

In 2025, HNX:PPP's revenue was 139.74 billion, an increase of 1.59% compared to the previous year's 137.55 billion. Earnings were 16.57 billion, an increase of 6.58%.

Financial Statements